The Research and Development Survey (RANDS) during COVID-19
The National Center for Health Statistics’ (NCHS) Research and Development Survey (RANDS) is a series of commercial panel surveys collected for methodological research purposes. In response to the COVID-19 pandemic, NCHS expanded the use of RANDS to rapidly monitor aspects of the public health emergency. The RANDS during COVID-19 survey was designed to include COVID-19 related health outcome and cognitive probe questions. Rounds 1 and 2 were fielded June 9–July 6, 2020 and August 3–20, 2020 using the AmeriSpeak® Panel. Existing and new approaches were used to: 1) evaluate question interpretation and performance to improve future COVID-19 data collections and 2) to produce a set of experimental estimates for public release using weights which were calibrated to NCHS’ National Health Interview Survey (NHIS) to adjust for potential bias in the panel. Through the expansion of the RANDS platform and ongoing methodological research, NCHS reported timely information about COVID-19 in the United States and demonstrated the use of recruited panels for reporting national health statistics. This report describes the use of RANDS for reporting on the pandemic and the associated methodological survey design decisions including the adaptation of question evaluation approaches and calibration of panel weights.